Long term persistence of clonal malaria parasite  lineages in the Colombian Pacific region by unknown
Echeverry et al. BMC Genetics 2013, 14:2
http://www.biomedcentral.com/1471-2156/14/2RESEARCH ARTICLE Open AccessLong term persistence of clonal malaria parasite
Plasmodium falciparum lineages in the Colombian
Pacific region
Diego F Echeverry1,2*, Shalini Nair3, Lyda Osorio2,4, Sanjay Menon5, Claribel Murillo2 and Tim JC Anderson3Abstract
Background: Resistance to chloroquine and antifolate drugs has evolved independently in South America,
suggesting that genotype - phenotype studies aimed at understanding the genetic basis of resistance to these and
other drugs should be conducted in this continent. This research was conducted to better understand the
population structure of Colombian Plasmodium falciparum in preparation for such studies.
Results: A set of 384 SNPs were genotyped in blood spot DNA samples from 447 P. falciparum infected subjects
collected over a ten year period from four provinces of the Colombian Pacific coast to evaluate clonality,
population structure and linkage disequilibrium (LD). Most infections (81%) contained a single predominant clone.
These clustered into 136 multilocus genotypes (MLGs), with 32% of MLGs recovered from multiple (2 – 28)
independent subjects. We observed extremely low genotypic richness (R = 0.42) and long persistence of MLGs
through time (median = 537 days, range = 1 – 2,997 days). There was a high probability (>5%) of sampling parasites
from the same MLG in different subjects within 28 days, suggesting caution is needed when using genotyping
methods to assess treatment success in clinical drug trials. Panmixia was rejected as four well differentiated
subpopulations (FST = 0.084 - 0.279) were identified. These occurred sympatrically but varied in frequency within the
four provinces. Linkage disequilibrium (LD) decayed more rapidly (r2 = 0.17 for markers <10 kb apart) than observed
previously in South American samples.
Conclusions: We conclude that Colombian populations have several advantages for association studies, because
multiple clone infections are uncommon and LD decays over the scale of one or a few genes. However, the
extensive population structure and low genotype richness will need to be accounted for when designing and
analyzing association studies.
Keywords: Plasmodium falciparum, Colombia, Clonality, Relatedness, Persistence, Genotypic richness, Population
structure, SNPs, Linkage disequilibrium, Association studiesBackground
Studies of parasite genetic structure are of practical
importance in low transmission malaria regions for a
number of reasons. First, long term persistence of identical
multilocus genotypes (MLGs) may generate an upward
bias in PCR-corrected estimates of treatment failure rates
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reproduction in any medium, provided the orbias. Second, the longer range of linkage disequilibrium
(LD) expected in such populations can simplify genetic
mapping since genomic regions influencing traits of inter-
est may be detected with a lower density of markers. At
the same time, however, population structure may intro-
duce bias into such analyses. Therefore, detailed evalua-
tions of both LD and population structure are needed to
design appropriate association studies in such regions.
Third, while low malaria transmission areas are respon-
sible for a small proportion of the world’s malaria cases,
such regions appear to play a disproportionate role in evo-
lution of drug resistance. For example, resistance to
chloroquine (CQ) has evolved twice in South America,ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Guinea [1]. However, there is no evidence that CQ resist-
ance has arisen in Africa, where ~90% of the world
malaria cases occur, and a similar story also holds for
resistance to pyrimethamine [2]. Finally, effective control
measures have reduced malaria transmission in many
hyperendemic regions of sub-Saharan Africa. Over time
we expect that malaria parasite population structure in
these regions may become more similar to that currently
observed in Southeast Asia and South America.
Malaria is endemic in 20 countries in Central and
South America, with Brazil and Colombia accounting
for ~65% of all reported cases [3]. Colombia has
approximately 100,000 malaria cases per year and >60%
of the Colombian population is at risk for malaria.
Malaria transmission is unstable with all age groups
affected, and nearly all malaria cases are symptomatic
[4]. Using genotyping of the antigenic genes merozoite
surface protein (msp) 1 and 2, parasite populations from
Quibdó city (Chocó, Colombia) were shown to be genet-
ically depauperate with low levels of multiclonal infec-
tions [5]. In fact, a single haplotype accounted for more
than 60% of all the 390 samples studied. A subset of 56
of these samples were further studied with five microsa-
tellites confirming very limited variation: 13 different
haplotypes were found among these 56 isolates [5]. This
low genetic diversity is consistent with other molecular
study performed in Panguí (Chocó) [6], Turbo and
Zaragoza (Antioquia, Colombia) [7] and with studies
performed in South America, but contrasts with similar
studies in Africa [8-11].
Most work on South American P. falciparum has
employed antigen or microsatellite markers. As data from
these markers are difficult to compare between laborato-
ries, we sought to use methods that are more portable.
Here, we examined the population genetics and popula-
tion structure of P. falciparum infections using 384 SNPs
in P. falciparum sampled from the Pacific region of
Colombia between 1993–2007. We used these data to:
(1) test methods for genome wide SNP typing using lim-
ited parasite DNA from dried bloodspots; (2) determine
the number of parasite populations present within the
region sampled; (3) measure the persistence of identical
multilocus genotypes in time and space, and (4) examine
patterns of LD across the genome. Our central goals are
to determine how parasite population structure impacts
interpretation of clinical drug trials and the design of
genetic association analyses in this region of Colombia.
Methods
Parasite samples
Microscopically confirmed P. falciparum samples included
in this study came from five cities of the Colombian
Pacific region: Tadó and Quibdó in the province of Chocó,Buenaventura in Valle, Guapi in Cauca, and Tumaco in
Nariño (Figure 1A, Table 1). Collectively, these four
provinces account for up to 75% of P. falciparum cases
reported in Colombia [4]. Strong differences in the trans-
mission of falciparum malaria are observed among these
locations (Figure 1B and Table 1). Finger-prick blood spot
samples were collected on filter paper (Whatman 3 MM,
Whatman International, Maidstone, England) from 447
Colombian P. falciparum samples. Samples were obtained
from primary infections of subjects with uncomplicated
malaria who took part in studies conducted by CIDEIM
from 1993 to 2007. Ninety five percent were obtained
from fresh blood and 5% from samples previously adapted
to culture. Informed consent was obtained from all the
subjects enrolled, as approved by CIDEIM Institutional
Review Board (IRB). We included nine P. falciparum
reference strains: 3D7 (collected in the Netherlands), 7G8
(Brazil), Dd2 (Indochina/Laos), FCB (Southeast Asia),
FCC2 (China), HB3 (Honduras), K1 (Thailand), Santa
Lucia (Guatemala) and V1/S (Vietnam) from the Malaria
Research and Reference Reagent Resource Center - MR4
(http://www.mr4.org), as controls for the genotyping
methodology.
DNA extraction and whole genome amplification (WGA)
For each sample, four or six mm punches of the blood
spot were used for DNA recovery and purification. We
used a three step process to prepare DNA for SNP geno-
typing: (1) DNA was recovered from blood spots using
the Gensolve kit (GenVault Corporation, Carlsbad, CA);
(2) the QIAamp DNA Blood Mini Kit (Qiagen, Valencia,
CA) was used to purify recovered DNA and concen-
trated using a speed vacuum (20 min at 45°C) to achieve
a final volume ~10 μL, and (3) the illustra GenomiPhi
V2 DNA amplification kit (GE Healthcare, Piscataway,
NJ) was used to amplify 1 μL of gDNA. The final volume
of DNA was 60 μL (eluted in TE buffer) and DNA was
quantified using a NanoDrop 1,000 spectrophotometer
(Thermo Fisher Scientific Inc, Wilmington, DL).
GoldenGate SNP genotyping
A custom GoldenGateW genotyping assay was designed
using 384 SNPs obtained from coding genes. These
included 126 synonymous and 258 non-synonymous
SNPs (Additional file 1). The SNPs were selected using
the query system on PlasmoDB (www.plasmodb.org)
[15]. We selected SNPs that were polymorphic (with a
minor allele observed in at least two Central and South
American samples), situated >50 kb from telomeres to
exclude antigenic genes, that were assigned a score of
>0.6 using the Illumina Design Tool (ILLUMINAW ADT,
Illumina, San Diego, CA). The SNPs were genotyped
using the GoldenGateW genotyping assay [16], following





















































Choco Valle Cauca Narino
A
B
Figure 1 Sampling of Plasmodium falciparum populations and malaria epidemiology in the Colombian Pacific region. A) Map of
Colombia - South America showing four malaria endemic provinces located in the Pacific region: Chocó, Valle, Cauca and Nariño, and the cities
where samples were collected. About 90% of the population in this region located between the Pacific Ocean and the Western branch of the
Andean Mountains are Afro-Colombians. Lines represent distance between sample collection sites: Quibdó-Tadó: ~66 km; Quibdó-Buenaventura:
~253 km; Buenaventura-Guapi: ~149 km and Guapi-Tumaco: ~109 km. B) Malaria endemicity in the four states defined by the annual parasite
incidence (API) between 2000 – 2007. Data was not available from 2000 – 2001 in Nariño. For complementary information see Table 1.
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per state per yeard
City
2000: 2616 1997: 2
Chocó 388476 25/102 77 An. darlingi* 2001: 6383 200: 6
(25%) An. nuneztovari 2002: 6089 2001: 13Quibdó 5°41’19”N-76°39’33”W 109121 (28%)
An. pseudopuntipennis* 2003: 7745 2002: 1
An. neivai * 2004: 3863 2004: 14
An. puntimacula* 2005: 4441 2005: 6
Tadó 5°16’03”N-76°33’57”W 15962 (4%)
2006: 4320 2006: 13
2007: 5025 2007: 22
2000: 985 1993: 4
Valle 4161125 8/57 49 An.albimanus, 2001: 1767 1994: 1
(14%) An. nuneztovari, 2002: 5003 1999: 4Buenaventura 3°25’52”N-77°03’17” W 324207 (8%)
An. pseudopuntipennis*, 2003: 1859 2000: 1
An. neivai* 2004: 4369 2002: 1
An. puntimacula* 2005: 4115 2004: 13
2006: 745 2005: 15
2007: 643 2006: 10
2000: 1209
Cauca 1268937 11/78 67 2001: 3770
(14%) An. albimanus 2002: 2670 1999: 1Guapi 2°34’17”N-77°53’15”W 28649 (2%)
An. nuneztovari 2003: 3657 2000: 1
An. neivai* 2004: 1177 2003: 65




















Table 1 Summary of Plasmodium falciparum samples, epidemiology data and malaria vectors in the Colombian Pacific region (Continued)
2000: ND 1999: 1
Nariño 1541956 31/163 132 2001: ND 2000: 2
(19%) An. albimanus 2002:) 17417 2001: 10Tumaco 1°48’34”N-78°45’46”W 161490 (11%)
An. neivai* 2003:) 7085 2002: 12
An. puntimacula* 2004:) 6250 2003: 56
2005:) 9992 2004: 2
2006:) 9245 2005: 23




a Information according to the 2005 Colombian National Census [12]; b Reports are based on field studies, underlie species are considered primary vectors in Colombia [13,14]; c Information provided by SIVIGILA –










































Figure 2 Distribution of Single Nucleotide Polymorphisms
(SNPs) used for genotyping. Location of 384 SNPs through the 14
chromosomes of P. falciparum. There were 6, 22, 12, 39, 27, 30, 36,
34, 14, 15, 31, 37, 33, and 48 SNPs on chromosomes 1 – 14,
respectively.
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BeadStudio package (Illumina, San Diego, CA). We
defined clusters of parasites with alternative bases (wild-
type or mutant) at each SNP: parasites falling in between
these two extremes were assumed to be mixed infections.
Clonality assessment, relatedness and persistence
We calculated the proportion of alleles shared (ps) between
all pairwise comparisons of all single clone parasites follow-
ing the procedure of Anderson et al. [17,18]. The genetic
distance matrix was estimated using ARLEQUIN v 3.1 soft-
ware [19], a UPGMA phenogram was constructed using
the metric 1 - ps with PHYLIP v 3.69 [20], and plotted
using FIGTREE software v 1.3.1 [21]. Parasite samples iden-
tical at all genotyped SNPs (i.e. clones) were identified by
inspecting the terminal branches of the phenogram. Para-
sites with unique haplotypes at all tested SNPs are referred
as multilocus genotypes (MLGs). We calculated genotypic
richness (R), a measure of the proportion of unique geno-
types in the population sample as R = G - 1/n - 1, were G is
the total number of MLGs found in n samples [22]. We
computed the probability of sampling the same MLG from
different infected patients separated by different time inter-
vals within each province. This analysis was done using the
clonal sub-range fix option included in the GenClone 2.0
software [23,24], with time intervals relevant for in vivo
antimalarial efficacy studies.
Population structure assessment
This analysis was conducted using one representative of
each MLG after exclusion of multiple infections. We
used the Bayesian model–based clustering algorithm
implemented in STRUCTURE v 2.1 [25,26] to investi-
gate genetic structure. We used an admixture model
with correlated allele frequencies [26], with a Markov
Chain Monte Carlo (MCMC) of 10,000 ‘burn-in’ steps
followed by 100,000 interactions and 20 replicate runs at
each K value (1 to 16). The optimal K partition was esti-
mated following the STRUCTURE directions and the
methodology proposed by Evanno et al. [27].
Estimation of linkage disequilibrium
HAPLOVIEW software was used to compute linkage
disequilibrium (LD) [28]. We calculated LD between
each pairwise combination of linked markers and plotted
the relationship between physical distances and LD. To
measure the extent of LD, we used the correlation coef-
ficient (r2). Analyses were completed for both in the
complete set of unique haplotypes and for the subpopu-
lations identified by STRUCTURE software. We esti-
mated the level of LD between unlinked markers (SNPs
in different chromosomes for each subpopulation) in
order to estimate the background LD caused by smallsample size in the populations, or relatedness, as was
performed by Van Tyne et al. [29].
Results
Efficient SNP genotyping using GoldengateW assay from
blood spots
Parasitemias of genotyped samples ranged from <0.01%
(including two samples with 80 parasites/μL) to 1.09% of
infected red blood cells. Following multiple displacement
amplification of DNA extracted from blood spots [30],
we obtained an average of ~12 μg of DNA per sample
with an OD260:OD280 ~1.8 although most of the ampli-
fied DNA came from human origin. All 17 samples
adapted to culture were successfully genotyped.
A total of 384 SNPs distributed across the 14 chromo-
somes of the parasite were genotyped (Figure 2, Additional
file 1), with an average of one SNP per 60 kb. Forty three
SNPs (11%) were rejected due to poor quality (poorly
resolved or scored in <90% samples) and 34 (9%) were
non variable SNPs (minor allele frequency - MAF <5%),
leaving 307 (80%) informative SNPs with MAF >5%
(Additional file 1). We genotyped 447 primary infections
and nine reference strains. Thirty two samples (7%) with
parasitemias between 150 and 18,200 parasites/μL had in-
complete SNP data (>10% of missing data) and 15 samples
were excluded due to conflict with identification. A total
of 400/447 (89.5%) Colombian Pacific coast primary infec-
tions were included in the statistical analyses (Table 1).
The reference strains DD2, HB3, 7G8 and Santa Lucia
were evaluated twice in different plates. The validation
rate (concordance level) between the same reference
strains in different plates to the total SNP calls was high,
99.1, 99.4, 99.7 and 96%, respectively (Additional file 2).
We also compared concordance between GoldenGate
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lable at PlasmoDB. Several discrepancies were found.
For FCB, DD2, 3D7, HB3 and 7G8, we observed high
concordance (between 95.1 to 99.4%), while for K1, V1/
S, FCC2 and Santa Lucia concordance was lower (88.1
to 92.6%) (Additional file 2). As the GoldenGateW geno-
typing is a robust technique, SNP discordances may be
explained by low sequencing coverage (1.25X) of these
samples [29].
Clonality assessment reveals strong relatedness and long
term persistence
Polyclonal infections (>1 clone of P. falciparum per sample)
were defined as the samples with >10 heterozygous SNP
calls and were found in 75/400 (19%) samples (Table 1).
For those samples, the mean number of heterozygous SNPs
was 27.7 (range 11 – 66). We observed 25, 14, 14, and 19%
multiple infections in Chocó, Valle, Cauca and Nariño pro-
vinces respectively. There was a strong positive correlation
between carriage of multiple genotypes and transmission
intensity (r2 = 0.99) (Figure 3).
A subset of 325 monoclonal samples from Chocó,
Valle, Cauca and Nariño were retained for further ana-
lysis (Table 1). These samples had 250 informative SNPs,
as several SNPs were not informative (MAF <5%) after
exclusion of polyclonal infections. The 325 monoclonal
parasites comprised 136 unique MLGs, with 44 (32%)
represented by MLGs infecting more than one patient
(range 2 – 28) (Figure 4A). MLG 036 comprises two
culture-adapted samples from Quibdó and Tadó that
were indistinguishable from the Dd2 reference strain
from Southeast Asia. Contamination during in vitro
adaptation (W2, the Dd2 progenitor, is cultured at
CIDEIM since 2000) or DNA manipulation may explain































Cases per 1000 people  (2000 -2007)
Figure 3 Association between malaria transmission and
multiple clone infection. Correlation between number of
multiclonal infections and malaria transmission intensity in the
Colombian Pacific region. Square, circle, diamond and triangle
represent isolates from Chocó, Nariño, Cauca and Valle respectively.The sampling period (03/15/1999 to 07/09/2007) cov-
ers >3000 days. Using the whole dataset, we observed 45
MLGs that persisted for more than one day (Figure 5A).
We examined the clonal persistence in time and space
of the 15 most common MLGs (range of 5 – 28 clones
per MLG) (Figure 5B). Eight MLGs (n = 67 parasites)
were restricted to a single province, while seven MLGs
(n = 92 parasites) were recovered from more than one
province. A surprisingly long persistence was found with
a median of 537.5 (range 1 – 2997) days. Thus, our data
suggest that parasite clones persist through the Pacific
region for up to eight years (Figures 5A and 5B). This is
equivalent to 48 parasite generations assuming six
generations per year [31].
In the four locations, the probability of sampling the
same MLG decayed slowly and remained between 0.03
and 0.11 at time intervals <500 days (Figure 5C). In
Valle, probabilities of sampling identical MLGs were
closed to 30% for patients sampled within the first 21
days.
Non panmitic population in P. falciparum samples from
Colombian Pacific region
From the STRUCTURE input file, the mean Var [LnP(D)]
showed an unimodal distribution reaching a plateau at
K = 4 (Figure 4B) and a relatively constant α value after
K = 4, stabilizing at <0.1, suggesting four different subpo-
pulations (Figure 4C). This concurs with Evanno’s meth-
odology [27] using the K vs. ΔK (Additional file 3). These
findings reject panmixia in the Colombian parasites
analyzed. The four subpopulations exhibit significant
differentiation with FST values ranging from 0.084 - 0.279
(Additional file 4). The subpopulation Col–1 is repre-
sented by 82 isolates in 46 MLGs, and were highly preva-
lent in the North Pacific region (Chocó province) with a
frequency >80% decreasing dramatically to the South; in
contrast, subpopulation Col–4 with 87 isolates in 21
MLGs was highly prevalent in Cauca (>70%) and its fre-
quency was lower to the Pacific North. Subpopulations
Col–2 with 86 isolates in 55 MLGs and Col-3 (70 isolates
in 14 MLGs) showed a more heterogeneous distribution,
comparable between Valle and Nariño, although Col-2
and Col-3 had the higher frequency (>40%), respectively
(Figure 4D); this suggests a high chance of parasite admix-
ture in these provinces. As expected, the lowest differen-
tiation between the provinces was found between Valle
- Nariño (FST = 0.023) while the highest was for Cauca–
Chocó (FST = 0.117) (Additional file 4). The UPGMA
tree based on allele sharing distances showed strong
support for the four clusters (Figure 4A).
Extent of linkage disequilibrium
We computed LD for the entire population and for the four










































Figure 4 Determination of multilocus genotypes and population structure from Colombian P. falciparum from the Pacific region.
A) UPGMA phenogram built with 325 monoclonal samples, using the distance metric 1 - proportion of shared alleles. The labels at the branch
tips indicate Colombian parasites MLGs or laboratory controls from MR4. The number in parenthesis shows the number of identical parasites
within a MLG (n = 136) and the colors of the branches indicate the four populations identified by the program STRUCTURE. B) Plot of Var [LnP(D)]
vs. K probability showing the best K subpopulation partition at K = 4; for complementary information see Additional file 3. C) Output from
STRUCTURE software. Each MLG is represented by a vertical line and each color represents a different subpopulation; many MLGs showed mixed
ancestry (length of the colored lines indicate the estimated proportion of membership of each MLG to that subpopulation). D) Distribution of the
four subpopulations across the provinces at the Colombian Pacific region. The frequency of each subpopulation is shown as a percentage.
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(n = 136), the mean r2 was 0.16 for markers spaced <10 kb
apart and decayed to background levels within ~240 kb.
We observed striking differences in the decay of LD values
in the four subpopulations (Figure 6), decaying slower in
subpopulation Col-3 and Col-4. Within subpopulations
Col-3 (n = 14) and Col-4 (n = 21) mean r2 was ~0.5 at
inter-marker distances <20 kb, complete pairwise LD
(r2 = 1) was observed for many marker pairs at distances
up to ~ 1200 kb, the mean r2 decayed to background
levels in ~ 500 kb. In addition, Col-3 and Col-4 showed
high background levels of LD (r2 = 0.11 and 0.08 re-
spectively) between markers on different chromosomes.
The subpopulation Col-2 (n = 55) exhibited the most
rapid decay in LD, and patterns of decay for this
subpopulation mirrored those observed in the whole
population (Figure 6).Discussion
Successful genotyping of 307 SNPs in 400 P. falciparum
infections from four provinces in the Colombian Pacific
region over a ten year period allows detailed description of
parasite population genetics in this region. These data re-
veal (a) parasite MLGs persisting for up to eight years
(median of 538 days), (b) stratification of parasites into
four subpopulations that occur sympatrically within sam-
pling locations, (c) LD decays by half in <10 kb, but varies
between subpopulations. We discuss the advantages of the
SNP genotyping method used, and the implications of our
findings for design of association studies and evolution of
drug resistance in low endemic malaria areas.
Effective genotyping using dried blood spots
In the present study, we were able to rapidly score mul-
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Figure 5 Analyses of clonality and persistence in multilocus
genotypes from Colombian Pacific region. A) Distribution of
persistence times in the whole dataset analyzed (325 samples
in 136 MLGs). B) Fifteen P. falciparum MLGs from Colombian
Pacific coast revealed clones from different locations at same
MLG and clonal persistence > eight years. C) Probability of
sampling parasites from the same MLG in each of the four
provinces in the Colombian Pacific region and overall
probability. The first five intervals of days represent days of











































Figure 6 Linkage disequilibrium analyses in the four
subpopulations and the complete dataset. Linkage disequilibrium
measure (r2) vs. physical distances between SNPs using the four
subpopulations determined by STRUCTURE software (Col-1 to Col-4)
and all subpopulations as a whole.
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of 250 informative SNPs for further genetic studies at
the local/regional level. The major advantage of SNPs
over microsatellites is that they are more abundant, mu-
tationally stable, located in genes and “portable”; in other
words, they are easily scored and comparable between
studies.
Clonality and persistence of MLGs in time and space
Genetic variability studies show a direct relationship
between degree of parasite endemicity and genetic vari-
ation [32,33]. In high endemic malaria areas, such as sub
Saharan Africa, multiclonal P. falciparum infections,
high genetic diversity, and low LD are common. In con-
trast, in low endemic areas, such as South American
countries, malaria patients are expected to have infec-
tions caused by a single clone with limited genetic diver-
sity and more extensive LD [8]. We found that 19% of
P. falciparum infections were multiclonal in samples col-
lected from the Colombian Pacific region. This is con-
sistent with previous studies in low endemic malaria
areas and contrasts with studies in Africa where the per-
centage of multiclonal infections can reach up to 90%
[34]. This correlation between multiclonal infections and
transmission intensity was confirmed here within low
endemic areas (Figure 3), suggesting that this metric
provides an indirect measure of transmission intensity
[35,36].
A decade ago, Anderson et al., using 12 microsatel-
lites, stated that P. falciparum from South America had
the lower level of genetic diversity worldwide, with 30
Colombian samples (collected in Antioquia province),
showing the lowest diversity [8]. Another study using 56
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lites, also suggested low diversity [5].
The genotypic richness (R) [22] was 0.42 for all the
monoclonal samples included in this study, the lowest
reported in comparison with other studies from similar
malaria eco-epidemiological features such as Venezuela,
Peru, Brazil, Cambodia and Thailand with R values of
0.60 – 0.98 [9,11,17,18,37-39]; however this measure is
strongly influenced by sampling intensity and hence
comparisons between countries may be biased [35]. Our
study confirmed low genotype richness in P. falciparum
from Colombia, with a third of the MLGs infecting ≥2
patients (Figure 4A) and long persistence (Figure 5A) in
cities separated up to more than 500 km (Figure 1). Our
results contrast with studies from neighboring countries
including Venezuela, Brazil and Peru, where genotype
richness is markedly higher and the number of poly-
clonal infections has increased (more than double) from
2003 to 2007 [9,38,40].
Implications for drug efficacy studies
PCR genotyping of parasite infections before and after
treatment is widely used to differentiate between
reinfection and recrudescence and to adjust measures
of treatment failure rates in antimalarial drug efficacy
studies [41,42]. However when parasite populations are
highly inbred, there is high probability of patients being
reinfected with the same parasite genotype [43]. To
evaluate this probability in Colombian samples, we
examined the probability of sampling identical geno-
types. In Valle province, this probability was the highest,
during the interval of 15–21 days (~30%), followed by
Chocó (29–42 days) and Nariño (22–28 days) with a
probabilities close to 15% and Cauca (43–63 days)
~10%. The overall population mean probabilities were
between 3 - 11% for up to 500 days (Figure 5C). These
results suggest that PCR evaluation should be used with
care in Colombia, because there is a strong probability
of misclassifying some new parasite infections as recru-
descences, thereby overestimating treatment failure
rates (Figure 5C).
Colombia implemented Artemisinin Combination The-
rapies (ACTs) at the end of 2006. Three drug efficacy stud-
ies were performed with these compounds in Antioquia
and Chocó provinces, showing 99 to 100% of efficacy
[44-47]. One subject from the rural area of Tadó (in Chocó)
presented parasitemia and fever at day 28 post treatment
with CoartemW; further genetic analyses of the msp1 gene
suggested a recrudescence [47]. However, it is unclear
whether this was a true treatment failure, or a case of re-
infection with the same genotype. The use of even more
polymorphic markers is not going to overcome the limita-
tions of PCR in this scenario. Three alternative approaches
could be used to aid interpretation of such studies: i) theuse of statistical approaches designed to account for this
bias, ii) definition of primary efficacy in terms of parasite
clearance rates and iii) the use of “malaria-free locations”
for malaria patients during post treatment surveillance
[43,48].Strong genetic structure in the Colombian Pacific
Both allele sharing methods and Bayesian clustering de-
fine four subpopulations and mixed ancestry in the area
of study (Figure 4), suggesting that our population struc-
ture results are robust. This is in line with previous studies
performed in Brazil and Peru, where three to five subpopu-
lations were revealed [9,10,39]. The presence of para-
site subpopulations in the Colombian Pacific coast may
be partially explained by the bottleneck in Plasmodium
populations, approximately 9,000 cases in 1960, produced
by the implementation of malaria control strategies [49]
and subsequent focal reemergence of parasites with differ-
ent genetic backgrounds.
The coexistence of different sub-populations within
locations is consistent with limited genetic exchange,
together with extensive migration among locations.
Plasmodium falciparum genetic interchange in Colom-
bia was suggested recently for parasites through the
Andean mountains and North and South of the Pacific
region [50]. Identification of identical MLGs in different
sampling locations also demonstrates migration of para-
site genotypes without breakdown due to recombination.
An epidemiological study performed in Quibdó with 670
P. falciparum infected patients, revealed that 66% of the
cases are from the urban and rural area of the city, while
the 33 and 1% are from neighboring municipalities and
provinces, respectively [5].
Local adaptation to different vectors may play a role in
the parasite population structure. For example, coadapta-
tion between vector and parasite has been suggested for
mosquitoes and Plasmodium vivax in Mexico [51], where
subpopulations of parasites differentially infected Anoph-
eles albimanus and An. pseudopuntipennis. Three primary
and three secondary vectors are found in the Pacific re-
gion (Table 1), and at least five different ecological sub-
regions had been identified (http://www.eoearth.org/).
Anopheles populations in Colombia vary locally in their
vectorial competence, breeding habitats, and feeding pre-
ferences [13]. One possible explanation is that parasite
population structure in the Pacific region is also shaped by
geographic restriction of compatible vectors. For example,
parasites from Col-1 subpopulation may be adapted to
An. darlingi in Chocó, since this vector had not been
registered in the other provinces of the Colombian Pacific
region [13,14]. Further experimental investigation is
necessary to test this hypothesis. The presence of An. dar-
lingi in Chocó, could explain the higher number of
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the most effective malaria vector in Latin America [13,14].
The model of metapopulation structure in P. falciparum
suggests the potential for spreading of drug resistance
alleles [52,53]. Parasites from Colombia may follow this
model as they show no panmixia and inbreeding. This fact
highlights the need to closely monitor the efficacy of ACTs
in Colombia and neighboring countries, since emergence
of drug resistance to different antimalarials occurred
and disseminated rapidly in this region [2]. Artemisinin
resistance has been confirmed in Southeast Asia [54], an
area with similar low transmission conditions as South
America. Finally, the presence of P. falciparum subpopula-
tions in the Colombian Pacific region could explain
the different patterns of drug susceptibility (in vivo and
in vitro), as the magnitude of resistance to amodiaquine,
sulphadoxine-pyrimethamine, and mefloquine varies be-
tween the South and North of this region [50,55].
Implications for association studies
Association studies require considerable investment of
time and resources. Therefore, it is critical to first dem-
onstrate that the traits of interest have a genetic basis
and to quantify the heritability in order to calculate ap-
propriate sample sizes [17,18]. Colombian P. falciparum
populations are well suited to study the heritability of a
trait of interest as the estimation of this parameter is
achievable when identical clones in populations have
been identified.
Colombian P. falciparum samples represent a challenge
for association studies owing to strong population struc-
ture, and presence of many identical or closely related
genotypes. In this study there were 136 unique genotypes
among 400 parasites sampled. Hence, only a third of
parasites sampled would be informative for association
analyses. Both population stratification and cryptic re-
latedness can generate spurious associations [56]. On the
other hand, the low numbers of multiple clone infections
simplifies detection of genotype/phenotype associations.
Both sampling and statistical approaches can minimize
bias in this situation. A two phase sampling strategy pro-
vides one possible approach to minimize cost and effort,
while maximizing study power. In phase one, preliminary
genotyping of the parasite population using 96–384 SNPs
can rapidly identify identical clones and multiple clone
infections. In phase two, a single representative of each
clone can be genotyped using higher densities of SNPs
using Illumina sequencing [57] or microarray based
approaches [58] and characterized for the trait of interest.
From the statistical standpoint, powerful mixed model
approaches developed by plant geneticists allow for effect-
ive control of both stratification and cryptic relatedness
[59]. This methodology was recently used to establish
the role of the PF10_0355 membrane protein in lowsusceptibility to arylaminoalcohols antimalarials [29]. These
approaches must be considered in areas of low transmis-
sion for P. falciparum association studies.
Offspring with limited to zero recombination are
expected to occur in South America [60]. Subpopulations
Col-3 and Col-4 exhibit the lower genotypic richness (R)
with R ~ 0.21, leading to higher LD in comparison with
the other populations. Subpopulations Col-1 and Col-2
both with R of ~ 0.59, are likely older and have more likeli-
hood of experiencing recombination. In our samples we
estimated persistence up to 48 generations, which reflects
transmission over many generations of segments of ances-
tral haplotypes comprising linked markers.
Despite evidence for high levels of inbreeding, the extent
of LD observed was lower than observed in other studies
of South American populations. We observed mean r2
value of 0.16 between markers spaced <10 kb apart in the
whole data set (Figure 6), while Neafsey et al. 2008
reported mean r2 of 0.7 for markers spaced <10 kb apart
for samples from Brazil [61]. Strong artifactual LD can be
generated by combining subpopulations with differing
allele frequencies in a single population sample. We there-
fore expected that LD would be elevated in the total popu-
lation relative to the individual subpopulations. In fact, we
observed the opposite (Figure 6).
The extent of LD varies among the four subpopulations.
Mean r2 for intermarker distances <10 kb range from 0.15
for Col-2 to 0.52 in Col-3 (Figure 6). Linkage disequilib-
rium in Col-3 and Col-4 also decays to background levels
(r2 between markers on different chromosomes) at ~500
kb, more gradually than for Col-1 and Col-2 (Figure 6).
Mixing with other parasite populations could also explain
the rapid decay in LD in the Col-2 subpopulation. The
Col-2 subpopulation is dominant in Buenaventura (Valle
State) the most important Colombian port in the Pacific
Ocean. The extensive movement of people through this
port may increase the chance of parasite admixture.
Several factors may contribute to the elevated LD
observed in Col-3 and Col-4. First, these subpopulations
are small (n = 14 and 21 for Col-3 and col-4 respectively)
so the extended LD may be an artifact of low sample
size. Three observations are consistent with this. First,
background levels of LD (between unlinked markers on
different chromosomes) are much higher in Col-3 and
Col-4 than in Col-1 and Col-2. Second, random resam-
pling of 14 haplotypes from the total sample of unique
genotypes (n = 136) increased values of r2 by an average
of 0.06 in each distance category. Third, relatedness or
recent admixture may contribute to elevated LD in
Col-3 and Col-4. These subpopulations show lower
expected heterozygosity (H = 0.25 for Col-3 and
H = 0.21 for Col-4) compared with Col-1 (H = 0.27)
and Col-2 (H = 0.34), suggesting that they may contain
closely related parasites. Finally, genotypic richness is
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ively) compared with Col-1 and Col-2 (R = 0.57 and
0.61 respectively). We suggest that observations of dif-
ferences in LD decay within parasite subpopulations
should be viewed with caution unless artifactual effects
of sample size and relatedness can be clearly rejected.
A feature of the LD information is important for
association mapping. Only 2.4% of markers situated
within 10 kb show r2 ≥ 0.8 in the whole dataset.
Hence, even in this low transmission region, genome
sequencing or efficient genotyping of tagging SNPs
will be needed to avoid false negative associations.
On the other hand, the rapid decay in LD should en-
able localization of causative SNPs to genome regions
containing 1–5 genes.
Conclusion
Our study shows the impact of low genotypic richness, per-
sistence of MLGs and population structure of P. falciparum
on the establishment, distribution and propagation of
MLGs in low endemic malaria areas. These features have
important implications for the design of ACT clinical effi-
cacy trials and genotype/phenotype association studies.
SNP surveys such as these, using moderate numbers of
markers, will be critical for maximizing the power, and
minimizing bias, in association studies in similar endemic
areas in South America using genome sequencing [57] or
high resolution microarray methods [58].
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